MALČÍKOVÁ, Jitka, Filip RÁZGA, Tomáš JURČEK, Dana DVOŘÁKOVÁ,
Daniela ŽÁČKOVÁ, Hana TOŠKOVÁ,
Ludmila ŠEBEJOVÁ, Jana ŠMARDOVÁ, Alexandra OLTOVÁ, Gabriela VAŇKOVÁ, Lenka JURAČKOVÁ,
Martin TRBUŠEK,
Šárka POSPÍŠILOVÁ,
Jiří MAYER a
Zdeněk RÁČIL. The BCR-ABL1 T315I mutation and additional genomic aberrations are dominant genetic lesions associated with disease progression in patients with chronic myelogenous leukemia resistant to tyrosine kinase inhibitor therapy.
Leukemia & Lymphoma. London: Informa Healthcare, Gordon and Breach, 2013, roč. 54, č. 9, s. 2083-2087. ISSN 1042-8194. Dostupné z: https://dx.doi.org/10.3109/10428194.2012.762649.